Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a step » _ step (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a step » _ step (Expand Search)
-
8041
Pyridoxine chlorhydrate forced degradation.
Published 2025“…In compounding practice, a medication can be done extemporaneously, leading to a risk of error. …”
-
8042
Thiamine chlorhydrate forced degradation.
Published 2025“…In compounding practice, a medication can be done extemporaneously, leading to a risk of error. …”
-
8043
Riboflavine forced degradation.
Published 2025“…In compounding practice, a medication can be done extemporaneously, leading to a risk of error. …”
-
8044
Biotin forced degradation.
Published 2025“…In compounding practice, a medication can be done extemporaneously, leading to a risk of error. …”
-
8045
Characteristics of dexmedetomidine use.
Published 2023“…Forty-five percent of patients had ≥50% days of rousable sedation. Hypotension occurred in 85% of patients. …”
-
8046
Baseline characteristics.
Published 2023“…Forty-five percent of patients had ≥50% days of rousable sedation. Hypotension occurred in 85% of patients. …”
-
8047
-
8048
-
8049
-
8050
-
8051
-
8052
Effect of BNN27 treatment on stride length and width in male and female mice.
Published 2016“…<p>Male Tg vehicle-treated mice exhibited a decrease in stride length (a, left) at p115 (p = 0.0136, Mann-Whitney <i>U</i> test) and stride width (b, left) at p95 (p = 0.0202, Mann-Whitney <i>U</i> test) relative to Wt vehicle-treated mice. …”
-
8053
-
8054
Summary of the experimental design.
Published 2023“…The third and fourth groups received a single daily dose of 50 mg/kg Safr (intraperitoneal) and 1 mg/kg Cands (oral), respectively. …”
-
8055
Percentage positive tests, tests turnaround times (24h-48h) and cumulative cases are reported from March 17, 2020 to November 28, 2020 in Toronto.
Published 2022“…<p>The percentage positive tests decrease from May 31 to August 24, when it starts increasing, showing, however a magnitude smaller than the first wave in March. …”
-
8056
-
8057
DIP grouping and aggregation system.
Published 2025“…Total costs in the non-surgical group showed a decreasing trend post-DIP intervention (β<sub>1</sub> + β<sub>3</sub> = −3.12). …”
-
8058
DIP coding logic example.
Published 2025“…Total costs in the non-surgical group showed a decreasing trend post-DIP intervention (β<sub>1</sub> + β<sub>3</sub> = −3.12). …”
-
8059
-
8060